GMAB 20.31 (+1.1%)
US3723032062BiotechnologyBiotechnology

Genmab (GMAB) Financial Metrics

This table shows a selected set of financial data points of Genmab (GMAB). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 6.66 0 32.18 140.04B 0.13 16.47B 7B 6.56B 4.35B 14.87B
2022 8.34 0 35.45 193.29B 0.2 14.51B 3.6B 6.95B 5.45B 9.89B
2021 4.52 0 57.47 169.92B 0.13 8.42B 1.98B 3.4B 2.96B 8.96B
2020 7.3 0 33.7 160.33B 0.26 10.11B 6.13B 6.76B 4.76B 7.26B
2019 3.44 0 43.29 93.77B 0.18 5.37B 1.22B 2.9B 2.17B 3.55B
2018 23.73 0 4.53 6.67B 0.2 3.03B 537.42M 1.7B 1.47B 532.91M
2017 17.77 0 5.82 6.42B 0.19 2.37B 1.5B 1.14B 1.1B 1.35B
2016 19.22 0 6.07 7.2B 0.26 1.82B 294.61M 1.17B 1.19B 307.02M
2015 12.56 0 7.28 5.56B 0.23 1.13B 176.06M 789.47M 763.51M 873.99M
2014 5.26 0 6.82 2.05B 0.13 850.39M 57.23M 313.73M 301.3M 359.09M
2013 2.16 0 9.77 1.1B 0.07 663.57M -138.36M 122.6M 112.36M 168.14M
2012 -10.58 0 -0.75 363.53M -0.3 484.64M 61.92M -471.92M -487.12M 66.99M
2011 -13.28 0 -0.28 168.53M -0.29 350.94M -444.43M -532.31M -596.37M 65.2M
2010 -7.16 0 -1.06 339.7M -0.14 582.08M 258.06M -239.9M -321.46M 100.95M
2009 -22.51 0 -0.35 351.98M -0.37 586.08M -586.84M -896.01M -1.01B 460.74M
2008 -21.62 0 0 0 -0.27 745.11M -566.35M -879.41M -965.09M 70.01M
2007 -8.72 0 0 0 -0.13 529.54M 493.06M -367.97M -383.37M 131.75M
2006 -11.26 0 0 0 -0.28 135.55M -381.56M -419.7M -438.24M 429.08M
2005 -12.59 0 0 0 -0.3 98.51M -211.08M -360.46M -393.59M 381.35M
2004 -15.69 0 0 0 -0.34 4.1M -375.96M -292.97M -415.21M 419.57M
2003 -14.33 0 0 0 -0.24 68.33M -317.07M -179.8M -327.11M 308.92M
2002 -21.46 0 0 0 0 0 -409.14M -331.16M -479.33M 252.95M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.